Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Deal Watch: Entasis, GARDP Partner On Novel Antibiotic For Drug-Resistant Gonorrhea

Executive Summary

Servier and Transgene will collaborate to apply viral vector technology to the development of CAR-T therapeutics, while Chinese vaccine maker Sinovac is taken private by an investment consortium.

Advertisement

Related Content

Celgene Eyes IO Growth With BeiGene China Pact
Stada CEO & CFO Resign; Rumors Circle Of A New Takeover bid
Sun Primes Late-Stage Psoriasis Asset With Samsung Manufacturing Deal
Another Big Pharma Embraces AI As Exscientia Bags GSK
Otsuka Ties Up With Mylan To Advance MDR-TB Drug In India?
What Now For Lonely Stada? Bain & Cinven Takeover Bid Collapses
Deal Watch: Array Partners With Ono On Cancer Drugs In Japan, South Korea
Clozel's CHF1bn Actelion Spin-Out Idorsia Awaits Janssen Buy-In
Accera Posts Phase III Alzheimer's Failure, But Moves Ahead With New Formulation
AZ Spins Out Entasis To Tackle Resistant Infections

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC099081

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel